147 related articles for article (PubMed ID: 14685699)
1. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.
Valen G
Basic Res Cardiol; 2004 Jan; 99(1):1-7. PubMed ID: 14685699
[TBL] [Abstract][Full Text] [Related]
2. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor kappa-B and the heart.
Valen G; Yan ZQ; Hansson GK
J Am Coll Cardiol; 2001 Aug; 38(2):307-14. PubMed ID: 11499717
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
[TBL] [Abstract][Full Text] [Related]
6. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.
Czibik G; Wu Z; Berne GP; Tarkka M; Vaage J; Laurikka J; Järvinen O; Valen G
Eur J Cardiothorac Surg; 2008 Nov; 34(5):976-84. PubMed ID: 18842422
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
Gu Q; Yang XP; Bonde P; DiPaula A; Fox-Talbot K; Becker LC
J Cardiovasc Pharmacol; 2006 Dec; 48(6):320-8. PubMed ID: 17204912
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity and myocardial adaptation to ischemia.
Valeur HS; Valen G
Basic Res Cardiol; 2009 Jan; 104(1):22-32. PubMed ID: 18931966
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
[TBL] [Abstract][Full Text] [Related]
10. [Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats].
Feng CS; Ma HC; Yue Y; Zhang YQ; Qu XD
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2110-4. PubMed ID: 15730629
[TBL] [Abstract][Full Text] [Related]
11. TNFalpha in ischemia/reperfusion injury and heart failure.
Schulz R; Aker S; Belosjorow S; Heusch G
Basic Res Cardiol; 2004 Jan; 99(1):8-11. PubMed ID: 14685700
[TBL] [Abstract][Full Text] [Related]
12. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
Liu XM; Jia Z; Zhou ZQ; Xu JG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
[TBL] [Abstract][Full Text] [Related]
13. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury.
Yada M; Shimamoto A; Hampton CR; Chong AJ; Takayama H; Rothnie CL; Spring DJ; Shimpo H; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):588-94. PubMed ID: 15457160
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
Sharony R; Frolkis I; Froylich D; Wildhirt SM; Shapira I; Reichart B; Nesher N; Uretzky G
Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release.
Kin H; Wang NP; Mykytenko J; Reeves J; Deneve J; Jiang R; Zatta AJ; Guyton RA; Vinten-Johansen J; Zhao ZQ
Shock; 2008 Jun; 29(6):761-8. PubMed ID: 18496137
[TBL] [Abstract][Full Text] [Related]
16. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
Lecour S
J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
[TBL] [Abstract][Full Text] [Related]
17. Role of apoptosis in reperfusion injury.
Eefting F; Rensing B; Wigman J; Pannekoek WJ; Liu WM; Cramer MJ; Lips DJ; Doevendans PA
Cardiovasc Res; 2004 Feb; 61(3):414-26. PubMed ID: 14962473
[TBL] [Abstract][Full Text] [Related]
18. Role of nuclear factor kappaB in cardiovascular health and disease.
Van der Heiden K; Cuhlmann S; Luong le A; Zakkar M; Evans PC
Clin Sci (Lond); 2010 Feb; 118(10):593-605. PubMed ID: 20175746
[TBL] [Abstract][Full Text] [Related]
19. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
[TBL] [Abstract][Full Text] [Related]
20. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]